| Financial Year |
March 31 2023 |
| Monetary Funds |
258,269,170.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
68,979.95 |
| Advances to Suppliers |
4,000.00 |
| Other Receivables |
6,864,010.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
33,383,444.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,034,634.08 |
| Total Current Assets |
315,624,239.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
14,013,656.88 |
| Fixed Assetes |
15,251,307.30 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
29,816,289.14 |
| Total Assets |
345,440,528.82 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,048,190.32 |
| Accounts Received In Advance |
2,213,510.20 |
| Employee Compensation Payable |
3,722,344.77 |
| Taxes Payable |
664,749.22 |
| Interest Payable |
-- |
| Dividend Payable |
226,625.00 |
| Other payables |
6,092,627.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
13,741,422.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
13,741,422.47 |
| Paid-In Capital(Or Share Stock) |
139,143,550.00 |
| Capital Surplus |
730,928.53 |
| Surplus Reserve |
34,827,045.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
119,126,530.69 |
| Minority Stockholder's Interest |
37,871,051.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
293,828,054.97 |
| Owner's Equity（Stockholder's Equity） |
331,699,106.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
345,440,528.82 |
